Dong-A Socio Holdings announced on the 27th Q2 consolidated revenue of 412.4 billion won and operating profit of 39 billion won, representing YoY increases of 18.9% and 38.3% respectively. The growth was driven by strong performance from key subsidiaries Dong-A Pharmaceutical and Yongma Logis. Dong-A Socio Holdings operates as a pharmaceutical holding company overseeing multiple business units including drug manufacturing, biopharmaceutical contract manufacturing, and logistics services.
Dong-A Socio Holdings Reports Q2 Consolidated Results
Dong-A Socio Holdings reported Q2 consolidated revenue of 412.4 billion won and operating profit of 39 billion won. Compared to the same period last year, revenue increased 18.9% and operating profit increased 38.3%. The company attributed the results to high growth from major subsidiaries Dong-A Pharmaceutical and Yongma Logis.
First Half Performance Shows Double-Digit Revenue Growth
For the first half, Dong-A Socio Holdings achieved consolidated revenue of 763.4 billion won and operating profit of 58.1 billion won. Revenue increased 13.0% and operating profit increased 19.8% compared to the same period last year.
Dong-A Pharmaceutical Drives Revenue with Bacchus and OTC Products
Dong-A Pharmaceutical achieved Q2 revenue of 228.2 billion won, a 25.7% increase compared to the same period last year. Operating profit reached 30.2 billion won, up 26.6% over the same period. The growth came from the Bacchus energy drink division and over-the-counter (OTC) pharmaceutical products.
By business segment, Bacchus recorded revenue of 87.8 billion won, OTC products generated 74.5 billion won, and health functional foods (HTC) brought in 52 billion won. These figures represent YoY increases of 26.6%, 36.5%, and 4.4% respectively.
BTgen CMO Revenue Declines on Timing of Client Orders
BTgen, a contract manufacturing organization (CMO) specializing in biopharmaceuticals, recorded Q2 revenue of 13.7 billion won, a 45.2% decrease compared to the same period last year. Operating profit fell 90.0% to 0.4 billion won. The company explained that major client orders are concentrated in the second half of the year.
Yongma Logis Posts Strong Growth from Existing and New Clients
Yongma Logis, a logistics specialist, achieved Q2 revenue of 120.5 billion won and operating profit of 6.9 billion won. Revenue increased 19.7% and operating profit increased 41.6% compared to the same period last year. The growth resulted from increased volume from existing clients and acquisition of new clients.
FAQ
What were Dong-A Socio Holdings' Q2 financial results?
Dong-A Socio Holdings reported Q2 consolidated revenue of 412.4 billion won and operating profit of 39 billion won, representing YoY increases of 18.9% and 38.3% respectively.
Which subsidiary contributed most to Dong-A Socio Holdings' Q2 growth?
Dong-A Pharmaceutical was the largest contributor, achieving Q2 revenue of 228.2 billion won (up 25.7% YoY) and operating profit of 30.2 billion won (up 26.6% YoY), driven by Bacchus and OTC product sales.
Why did BTgen's revenue decline in Q2?
BTgen's Q2 revenue fell 45.2% to 13.7 billion won because major client orders are concentrated in the second half of the year rather than Q2.
